SecBot SecBot

HTFL

Heartflow, Inc.
Nasdaq· Surgical & Medical Instruments & Apparatus· Inc. DE· CIK 0001464521 Healthcare & Medical Devices
$56.72 +0.01 (+0.02%)
Oct 26 4:00 PM ET · prev $56.71
Market cap
$4.8B
Mid cap
Consensus
Buy
81% Buy or better · 16 analysts
Median target
$50.00
−12% · range $39.00–64.00
Next earnings
Nov 12
in 17 days
1 year
+47.9%
from $38.34 · Oct 27
30 days
+13.6%
from $49.92
52-week range
$20.49–56.72
at the high
Avg volume 20D
1.62M
shares / day
Short interest
6.81M
≈7.8% of shares · +21.1%
Days to cover
3.3
at average volume
Insider net
−$17.0M
0 buyers · 3 sellers · since May 18
New fund stakes
3
Q2 2026 13F · 1 exit
SecBot read BEARISH 13 reports · 90 days
Balance 4 bearish · 2 bullish · 7 neutral oldest → newest, height = score
Avg score ·High conf. 5/13 ·Next Earnings date, Nov 12, 2026
Strongest BEARISH Campbell Rogers, an officer of Heartflow, Inc., filed a Form 144 on October 22, 2026, indicating intent to…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InsidersBEARISH

    3 insiders sold $17.0M.

  • InstitutionsBULLISH

    Q2 2026: 48 added (3 new), 9 trimmed or exited. Largest new: Bnp Paribas Asset Management Holding S.A $27.3M, Massachusetts Financial Services /Ma/ $14.6M.

  • AnalystsBULLISH

    13 of 16 rate it Buy or better. Median target $50.00 (−12%).

  • Short sellersBUILDING

    Short interest +21.1% to 6.81M shares. 3.3 days to cover, ≈7.8% of shares.

  • TrendUPTREND

    14% above its 50-day average. New closing high $56.72 on Oct 26.

Who's buying

13F· Q2 2026
3
new positions
1
exit
$53.2M
in new stakes
FundMoveSharesValue
WELLINGTON MANAGEMENT GROUP LLPTRIM7,864,226$230.7M
BlackRock, Inc.DOUBLED5,197,747$152.5M
VANGUARD PORTFOLIO MANAGEMENT LLCADD3,584,428$105.2M
VANGUARD CAPITAL MANAGEMENT LLCADD2,753,206$80.8M
Point72 Asset Management, L.P.DOUBLED1,721,279$50.5M
ALLIANCEBERNSTEIN L.P.ADD1,924,268$46.8M
STATE STREET CORPDOUBLED1,465,895$43.3M
GEODE CAPITAL MANAGEMENT, LLCDOUBLED1,360,391$39.9M

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

16 analysts
Buy 81% rate it Buy or better
Strong Buy5Buy8Hold3Sell0Strong Sell0
12-month targets · 8 analysts

Price is inside the target range. Median implies −12%.Targets as of Oct 26, 2026.

Recent actions
DateFirmActionRating
Oct 20, 2026Piper Sandler
REITERATE
REITERATEOverweight
Sep 22, 2026Canaccord Genuity
MAINTAIN
MAINTAINBuy
Sep 9, 2026UBS
INITIATE
INITIATENeutral
Aug 14, 2026Canaccord Genuity
MAINTAIN
MAINTAINBuy
Aug 14, 2026Morgan Stanley
MAINTAIN
MAINTAINEqual-Weight
Aug 14, 2026Piper Sandler
REITERATE
REITERATEOverweight

Insider ledger

Form 4
$0
bought · 0 insiders
$17.0M
sold · 3 insiders
DateInsiderTypeValue
Oct 12, 2026
Farquhar John C.M.
Chief Executive Officer
SELL$1.9M
Sep 18, 2026
Verghese Vikram
Chief Financial Officer
SELL$850.9K
Sep 18, 2026
Rogers Campbell
Chief Medical Officer
EXERCISE$102.7K
Sep 18, 2026
Rogers Campbell
Chief Medical Officer
EXERCISE$1.9K
Sep 18, 2026
Rogers Campbell
Chief Medical Officer
SELL$987.1K
Sep 17, 2026
Verghese Vikram
Chief Financial Officer
SELL$379.8K
Sep 15, 2026
Verghese Vikram
Chief Financial Officer
SELL$33.4K
Sep 14, 2026
Verghese Vikram
Chief Financial Officer
SELL$230.7K

Earnings setup

Estimates
Nov 12
reports in 17 days

Revision history: 🔒 Fresh data, subscribers only

PeriodEPS est.Range30D rev.Revenue
Current Q🔒 Fresh data, subscribers only
Next Q🔒 Fresh data, subscribers only
Current FY🔒 Fresh data, subscribers only
Next FY🔒 Fresh data, subscribers only

Short side

FINRA· Sep 30, 2026
6,813,775
shares short
+21.1%
vs prior settlement
3.3
days to cover
≈7.8%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 22, 2026 SEC
Campbell Rogers, an officer of Heartflow, filed a Form 144 notice of intent to sell 23,933 shares of common stock…
144 — Impact 3/10
Oct 22, 2026 SEC
Campbell Rogers, an officer of Heartflow, Inc., filed a Form 144 on October 22, 2026, indicating intent to sell 5,654…
144 — Impact 5/10
Oct 19, 2026 SEC
Heartflow, Inc. announced it will report its Q3 2026 results on November 12, 2026.
PRESS-RELEASE — Impact 1/10
Oct 19, 2026 Earnings
Heartflow to Report Third Quarter 2026 Financial Results on November 12, 2026
SAN FRANCISCO, Oct. 19, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the lea
Oct 12, 2026 Insider
Farquhar John C.M. sold 38,900 shares
Chief Executive Officer @ $49.57 ($1.9M)
Sep 18, 2026 Insider
Verghese Vikram sold 16,766 shares
Chief Financial Officer @ $50.75 ($850.9K)
Sep 18, 2026 Insider
Rogers Campbell acquired via exercise 12,329 shares
Chief Medical Officer @ $8.33 ($102.7K)
Aug 28, 2026 Press
Heartflow announced late-breaking one-year results from the independent, government-funded FUSION trial at ESC…
Impact 7/10
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Nov 12, 2026
Earnings date
HTFL Q3 2026 Earnings Scheduled — 2026-11-12
Recent
Oct 19, 2026
Earnings
Heartflow to Report Third Quarter 2026 Financial Results on November 12, 2026
SAN FRANCISCO, Oct. 19, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for diagnosing and…
Sep 30, 2026
Short interest
Short Interest: HTFL up 21% to 6.8M shares
Settlement 2026-09-30 | Days to cover: 3.34 | ≈7.84% of shares outstanding (est.)
Aug 28, 2026
FDA
Late Breaking Data from Independent Government-Funded Trial at ESC Shows Heartflow FFRCT Analysis Reduces Unnecessary Invasive Heart Procedures by Nearly Half
FUSION trial presented at ESC and published in Journal of the American College of Cardiology demonstrates adding non-invasive lesion-specific…
Aug 13, 2026
Earnings
Heartflow Reports Second Quarter 2026 Financial Results and Raises Full Year 2026 Guidance
SAN FRANCISCO, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for diagnosing coronary…
Aug 13, 2026
Earnings date
HTFL Q2 2026 Earnings Scheduled — 2026-08-13

SecBot reports

23 filings · 2 press releases · 3 bullish · 5 bearish · 1 mixed · 14 neutral
All HTFL filing & press-release reports (25)